clinical trials for semaglutide Long-term weight loss effects of in obesity without diabetes in the SELECT trial New Wegovy clinical trial finds

Additionally, Semaglutide GLP-1 injections can also help obese patients lose weight by reducing appetite and promoting feelings of fullness

Protective group handling systems 4

These adverse effects often improve with time or can be managed through dose adjustments, dietary modifications, or symptomatic treatment

For a detailed comparison, see our guide to Wegovy 7.2 mg vs 2.4 mg

Understanding these interactions helps prevent complications such as hypoglycemia when combined with insulin or sulfonylureas, ensures proper absorption of medications like levothyroxine, and optimizes timing for oral semaglutide (Rybelsus)